Related Experiment Video
Updated: Oct 19, 2025

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
M ycoplasma pneumoniae carriage evades induction of protective mucosal antibodies
Ruben Cornelis Anthonie de Groot1, Silvia Cristina Estevão1, Patrick Michael Meyer Sauteur2
1Dept of Pediatrics, Laboratory of Pediatrics, Erasmus MC University Medical Centre Rotterdam - Sophia Children's Hospital, Rotterdam, The Netherlands.
Background:
Mycoplasma pneumoniae is the most common bacterial cause of pneumonia in children hospitalised for community-acquired pneumonia (CAP). Prevention of infection by vaccines may be an important strategy in the presence of emerging macrolide-resistant M. pneumoniae. However, knowledge of immune responses to M. pneumoniae is limited, complicating vaccine design.
Methods:
We studied the antibody response during M. pneumoniae respiratory tract infection and asymptomatic carriage in two different cohorts.
Results:
In a nested case-control study (n=80) of M. pneumoniae carriers and matched controls we observed that carriage by M. pneumoniae does not lead to a rise in either mucosal or systemic M. pneumoniae-specific antibodies, even after months of persistent carriage. We replicated this finding in a second cohort (n=69) and also found that during M. pneumoniae CAP, mucosal levels of M. pneumoniae-specific IgA and IgG did increase significantly. In vitro adhesion assays revealed that high levels of M. pneumoniae-specific antibodies in nasal secretions of paediatric patients prevented the adhesion of M. pneumoniae to respiratory epithelial cells.
Conclusions:
Our study demonstrates that M. pneumoniae-specific mucosal antibodies protect against bacterial adhesion to respiratory epithelial cells, and are induced only during M. pneumoniae infection and not during asymptomatic carriage. This is strikingly different from carriage with bacteria such as Streptococcus pneumoniae where mucosal antibodies are induced by bacterial carriage.
Insights
Mucosal antibodies against Mycoplasma pneumoniae are induced during infection, not carriage. These antibodies prevent bacterial adhesion, offering insights for vaccine development against childhood pneumonia.
Area of Science:
- Immunology
- Microbiology
- Pediatrics
Background:
- Mycoplasma pneumoniae is a leading cause of pediatric community-acquired pneumonia (CAP).
- Emerging macrolide resistance in M. pneumoniae necessitates alternative prevention strategies like vaccines.
- Limited understanding of immune responses to M. pneumoniae hinders vaccine design.
Purpose of the Study:
- To investigate antibody responses during Mycoplasma pneumoniae respiratory tract infection and asymptomatic carriage.
- To determine if M. pneumoniae carriage induces mucosal or systemic antibody responses.
- To assess the functional role of M. pneumoniae-specific antibodies in preventing bacterial adhesion.
Main Methods:
- Studied antibody responses in two distinct pediatric cohorts.
- Employed a nested case-control study design (n=80) comparing carriers and controls.
- Utilized in vitro adhesion assays to evaluate antibody function.
Main Results:
- Asymptomatic M. pneumoniae carriage did not elevate mucosal or systemic antibodies.
- M. pneumoniae infection significantly increased mucosal IgA and IgG levels.
- High levels of M. pneumoniae-specific antibodies in secretions inhibited bacterial adhesion to respiratory cells.
Conclusions:
- M. pneumoniae-specific mucosal antibodies protect against bacterial adhesion to respiratory epithelial cells.
- These protective antibodies are induced solely during active infection, not asymptomatic carriage.
- Findings contrast with other bacteria like Streptococcus pneumoniae, where carriage induces mucosal antibodies.
Related Concept Videos
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...

